Maarten Jacquemyn

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Top Venues

Science advances

Nature genetics

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Merel Oeyen, Clément J F Heymann, Maarten Jacquemyn, Dirk Daelemans, Dominique Schols
The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance. Biosensors 14 (8) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Merel Oeyen, Clément J F Heymann, Maarten Jacquemyn, Dirk Daelemans, Dominique Schols
The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance. Biosensors 14 (8) (2024)
Merel Oeyen, Clément J F Heymann, Maarten Jacquemyn, Dirk Daelemans, Dominique Schols
The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance. Biosensors 14 (8) (2024)
Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M Schlenner, Sabine Tejpar, Dirk Daelemans, Massimilliano Mazzone, Abhishek Dinkarnath Garg
Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science advances 10 (29) (2024)
Keren Lasker, Steven Boeynaems, Vinson Lam, Daniel Scholl, Emma Stainton, Adam Briner, Maarten Jacquemyn, Dirk Daelemans, Ashok Deniz, Elizabeth Villa, Alex S Holehouse, Aaron D Gitler, Lucy Shapiro
The material properties of a bacterial-derived biomolecular condensate tune biological function in natural and synthetic systems. Nature communications 13 (1) (2022)
Eline Boons, Tatiane C Nogueira, Tim Dierckx, Soraya Maria Menezes, Maarten Jacquemyn, Sharon Tamir, Yosef Landesman, Lourdes Farré, Achiléa Bittencourt, Keisuke Kataoka, Seishi Ogawa, Robert Snoeck, Graciela Andrei, Johan Van Weyenbergh, Dirk Daelemans
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis. Blood cancer journal 11 (2) (2021)
Jim Baggen, Leentje Persoons, Els Vanstreels, Sander Jansen, Dominique Van Looveren, Bram Boeckx, Vincent Geudens, Julie De Man, Dirk Jochmans, Joost Wauters, Els Wauters, Bart M Vanaudenaerde, Diether Lambrechts, Johan Neyts, Kai Dallmeier, Hendrik-Jan Thibaut, Maarten Jacquemyn, Piet Maes, Dirk Daelemans
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nature genetics 53 (4) (2021)
Natalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long, Trinayan Kashyap, Christian Argueta, Yosef Landesman, Mehlika Hazar-Rethinam, Samuel Boros, Benedict Panizza, Maarten Jacquemyn, Dirk Daelemans, Orla M Gannon, Nicholas A Saunders
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas. Science translational medicine 10 (447) (2019)